Oximio Ukraine implements business continuity plan in response to war

Oximio is a global end-to-end logistics provider for clinical trials with over 19 years of experience in the industry.

Despite the brutal impacts on our Ukrainian founding country in the past year, this has inspired us to strive to deliver not only for the company but as ambassadors for all the voices of Ukrainian business and communities and the international partnerships and friendships that we forge.

Since the full-scale invasion, Oximio Ukraine was the first clinical trials service provider to resume operations in Ukraine in March 2022.